J. Bennett

发表

Genome‐wide linkage of 77 families from the African American Hereditary Prostate Cancer Study (AAHPC)

J. Carpten, E. Gillanders, J. Trent, 2007, The Prostate.

Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC study

J. Carpten, J. Trent, C. Royal, 2004, Prostate Cancer and Prostatic Diseases.

African-American heredity prostate cancer study: a model for genetic research.

J. Carpten, J. Trent, C. Royal, 2001, Journal of the National Medical Association.

Racial differences in pathogenetic mechanisms, prevalence, and progression of benign prostatic hyperplasia.

W. Rayford, Rodney Davis, W. Baker, 2006, Urology.

Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study

E. Fukuma, Masato Takahashi, K. Jung, 2021, Breast Cancer.

Association of HPC2/ELAC2 and RNASEL non‐synonymous variants with prostate cancer risk in African American familial and sporadic cases

J. Carpten, R. Kittles, Srinivasan Vijayakumar, 2008, The Prostate.

A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history

F. Collins, J. Carpten, J. Trent, 2005, Journal of Medical Genetics.

Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study.

J. Carpten, J. Trent, C. Royal, 2000, Annals of epidemiology.

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

J. O’Shaughnessy, M. Cazzaniga, S. Ohsumi, 2020, Breast Cancer Research.